Core A: Administrative
Core A: Administrative
批准号:
10295513
负责人:
ALISON M GOATE
金额:
$16.61万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-01 至 2026-08-31
关键词:
17q21Advisory CommitteesAwarenessBenchmarkingBudgetsChromosomesCollaborationsCommon Data ElementCommunicationCommunitiesDataDementiaDevelopmentEffectivenessEnsureEvaluationEventFeedbackFundingGeneticGeographyGoalsGovernmentGrowthHaplotypesHuman ResourcesInduced pluripotent stem cell derived neuronsInstitutionInterdisciplinary StudyInternationalKnowledgeLeadershipLos AngelesMaintenanceMeasuresMissionMolecularNational Institute of Neurological Disorders and StrokeNerve DegenerationNeurobiologyNeurogliaNew YorkPatient advocacyProcessProteomicsRegulationResearchResearch PersonnelResourcesRiskRoleSan FranciscoScienceSiteStructureTauopathiesTechnologyTimeTimeLineUnited States National Institutes of HealthWorkbrain tissuedata exchangedata sharingdata sharing networksdesigninnovationinterdisciplinary approachmedical schoolsmeetingsoutreachprogramstau Proteinstranscriptomicsweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY (CORE A: ADMINISTRATIVE CORE)
The purpose of the Administrative Core (Core A) is to ensure execution of our mission to conduct innovative,
interdisciplinary research to identify and validate the molecular mechanisms contributing to tauopathy
risk/protection associated with the H1/H2 haplotypes of the 17q21.31 region. The Center involves 3
geographically distributed sites in New York (Icahn School of Medicine at Mount Sinai), Los Angeles (UCLA)
and San Francisco (UCSF). Interactions will occur at two levels: scientific (exchange of information and data,
sharing of resources and specialized personnel) and administrative (organization of meetings and interactions
within and outside the CWOW). The primary goal of Core A is to connect these physically separate sites by
serving as a hub to facilitate interaction and communication between Core and Project leaders, investigators,
and external scientific communities, and ensure efficient governance and oversight of the Center. This Core will
ensure optimal utilization of center resources through maximization of institutional strengths and national and
global opportunities to broaden knowledge about the molecular mechanisms underlying risk/protection for
sporadic and familial tauopathy associated with H1/H2 haplotypes. This core is responsible for articulating the
research agenda and ensuring that it is effectively accomplished. Core A will accomplish this through a structure
that includes an Executive Steering Committee (ESC) led by the Director (Dr. Alison Goate) and the two
associate directors (Drs. Geschwind and Kampmann) as well as Core leaders. The ESC will insure that the
CWOW, national and international FTD resources are leveraged to the advantage of the CWOW and those of
the wider FTD community. An External Advisory Committee will provide guidance and review to
the CWOW leadership and communicate with NINDS Program Staff. The leadership will assure that the Center
is aware of national and international commitments as well as of opportunities to maximize our effectiveness. In
this capacity specific responsibilities include financial, administrative and regulatory management. This
Core will also oversee the growth of early stage investigators within the center. We propose two topically
related Projects supported by three Research Cores that leverage cutting-edge proteomic
and transcriptomic approaches in brain tissue and induced pluripotent stem cell derived neurons and glia
to determine the mechanisms contributing to tauopathy risk/protection associated with the H1/H2 haplotypes of
the 17q21.31 region. The Data Core (Core D) will serve as a hub for integrating all data produced by Projects
and Cores to be shared within and outside the CWOW. Core A will organize regular meetings to ensure
progress, open communication and resources are available to serve Project and Core goals, that Projects and
Cores have maximal opportunity to interact, and that Projects and Cores progress according to timelines and
meet benchmarks of accomplishment. Core A and the Data Core will work together to develop and maintain a
Center website.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuroprotective signaling and transcriptional pathways in microglia associated with Alzheimer's disease
-
批准号:10552538
-
项目类别:
-
资助金额:$119.92万
-
财政年份:2022
-
负责人:ALISON M GOATE
-
依托单位:
2022 Neurobiology of Brain Disorders GRC and GRS
-
批准号:10468475
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2022
-
负责人:ALISON M GOATE
-
依托单位:
Neuroprotective signaling and transcriptional pathways in microglia associated with Alzheimer's disease
-
批准号:10301271
-
项目类别:
-
资助金额:$122.41万
-
财政年份:2022
-
负责人:ALISON M GOATE
-
依托单位:
Genetic modifiers of APOE-related risk for AD
-
批准号:10667481
-
项目类别:
-
资助金额:$58.16万
-
财政年份:2021
-
负责人:ALISON M GOATE
-
依托单位:
Project 1: Determination of molecular differences caused by tauopathy-associated H1 and H2 haplotypes
-
批准号:10295517
-
项目类别:
-
资助金额:$77.65万
-
财政年份:2021
-
负责人:ALISON M GOATE
-
依托单位:
Biology and pathobiology of apoE in aging and Alzheimer's disease
-
批准号:10407934
-
项目类别:
-
资助金额:$657.14万
-
财政年份:2021
-
负责人:ALISON M GOATE
-
依托单位:
Biology and pathobiology of apoE in aging and Alzheimer's disease
-
批准号:10667435
-
项目类别:
-
资助金额:$652.39万
-
财政年份:2021
-
负责人:ALISON M GOATE
-
依托单位:
Genetic modifiers of APOE-related risk for AD
-
批准号:10407948
-
项目类别:
-
资助金额:$58.16万
-
财政年份:2021
-
负责人:ALISON M GOATE
-
依托单位:
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
-
批准号:10435506
-
项目类别:
-
资助金额:$158.77万
-
财政年份:2020
-
负责人:ALISON M GOATE
-
依托单位:
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
-
批准号:10159826
-
项目类别:
-
资助金额:$159.55万
-
财政年份:2020
-
负责人:ALISON M GOATE
-
依托单位:
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
-
批准号:10642872
-
项目类别:
-
资助金额:$158.47万
-
财政年份:2020
-
负责人:ALISON M GOATE
-
依托单位:
Genetics and Genomics Core
-
批准号:10406874
-
项目类别:
-
资助金额:$36.59万
-
财政年份:2020
-
负责人:ALISON M GOATE
-
依托单位:
Genomic approach to identification of microglial networks involved in Alzheimer’s disease risk
-
批准号:9922452
-
项目类别:
-
资助金额:$10.92万
-
财政年份:2018
-
负责人:ALISON M GOATE
-
依托单位:
Genomic approach to identification of microglial networks involved in Alzheimer disease risk
-
批准号:10228580
-
项目类别:
-
资助金额:$85.29万
-
财政年份:2018
-
负责人:ALISON M GOATE
-
依托单位:
Genomic approach to identification of microglial networks involved in Alzheimer disease risk
-
批准号:10468712
-
项目类别:
-
资助金额:$83.55万
-
财政年份:2018
-
负责人:ALISON M GOATE
-
依托单位:
Genomic approach to identification of microglial networks involved in Alzheimer’s disease risk
-
批准号:9751702
-
项目类别:
-
资助金额:$84.49万
-
财政年份:2018
-
负责人:ALISON M GOATE
-
依托单位:
Understanding the mechanism of SPl1 dependent Alzheimer disease risk
-
批准号:9194167
-
项目类别:
-
资助金额:$422.38万
-
财政年份:2016
-
负责人:ALISON M GOATE
-
依托单位:
Use of Endophenotypes in the Search for Alzheimer's Disease Risk Genes
-
批准号:8311728
-
项目类别:
-
资助金额:$56.62万
-
财政年份:2010
-
负责人:ALISON M GOATE
-
依托单位:
Use of Endophenotypes in the Search for Alzheimer's Disease Risk Genes
-
批准号:8136599
-
项目类别:
-
资助金额:$41.12万
-
财政年份:2010
-
负责人:ALISON M GOATE
-
依托单位:
Use of Endophenotypes in the Search for Alzheimer's Disease Risk Genes
-
批准号:9037426
-
项目类别:
-
资助金额:$40.47万
-
财政年份:2010
-
负责人:ALISON M GOATE
-
依托单位:
海外基金